    Charles Eyler | Puma Biotechnology Inc | ZoomInfo.com    Charles Eyler | Puma Biotechnology Inc | ZoomInfo.com









Eyler Charles R - Insider Stock Trading - OpenInsider











Sector

All Sectors

Group by Sector


Aerospace
Agriculture
Automobile
Building
Business Services
Chemical
Electrical
Energy
Fashion
Financial
Food & Beverage
Fund
Healthcare
Household
Insurance
Machinery
Media
Metals
Mining
Other
Personal Services
Real Estate
Retail
Technology
Telecom
Transportation
Utility




Industry

All Industries

Group by Industry






Insiders
Filings


All
Purchases
Sales

CIK: 1358246 - Address: C/o Puma Biotechnology, Inc., 10880 Wilshire Blvd., Suite 2150, Los Angeles, CA 90024 2 results 

						Links
						


SECYahooGoogleFinvizTradingViewStockChartsStockTwitsDownload CSV 













TC
Stat
Stk
Ins
Fil
+d
+w
+m
+q
+h
+y
avg


S%ret1112-6515004S%wins01000025 




Filing Date
T Date
Ticker
IssuerInc Sector
IndIndustry
Owner
oSt
Rel
Title
T
TVal
Price
L
Qty
oc
Own
H
r2y
r1y
r6m
r3m
r6w
r3w
r7d
r3d
f1d
f1w
f1m
f3m
f6m
f1y



7/24/17 17:147/20/17PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsEyler Charles RCAOSEE REMAS-6395.150-1-230D
1/24/17 17:531/20/17PBYIPuma Biotechnology, Inc.DEHealthDrugPharmaceutical PreparationsEyler Charles RCAOSEE REMAS-2733.2425-1-810D-84-31-25-29-151-9-132-6515



DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing



S - SaleSale of securities on an exchange or to another person

S - Sale+OESale of securities on an exchange or to another person (after option exercise)

F - TaxPayment of exercise price or tax liability using portion of securities received from the company

P - PurchasePurchase of securities on an exchange or from another person


Return to top
Contact
Copyright © 2017 OpenInsider.com. All rights reserved.







SEE REMARKS of Puma Biotechnology Inc (NASDAQ:PBYI), Eyler Charles R, sells 662 shares worth ,991









































Stay Connected

Latest Posts in RSS

BusinessEntertainmentFeatured NewsFeatured Press ReleaseFinanceHealthLifestyleNationNon FirstPageOriginalPress ReleaseReviewShoppingSportsStocksTechnologyTravelWorld


Latest Comments in RSS


 / 













EmpoweredNews
World News Summary Helping You Stay Informed









Business
Finance
Sports
Entertainment
Health
Technology
Travel
Shopping




Our Writers
About Us
Privacy Policy
Contact Us
Advertise
Press Releases
















SEE REMARKS of Puma Biotechnology Inc (NASDAQ:PBYI), Eyler Charles R, sells 662 shares worth $62,991
According to Puma Biotechnology Inc's most recent Form 4 filing with the SEC dated Jul 24 05:14 PM, company SEE REMARKS, Eyler Charles R disclosed selling 662 shares at a cost of $95.15. At the time of this transaction (Jul 20), this trade was worth $62,991 in total. As of Jul 20, Eyler Charles R now owns 30,018 shares in total worth about $2,830,697.4. 
For the last few recent trades made by Puma Biotechnology Inc (NASDAQ:PBYI) SEE REMARKS, Eyler Charles R, we have the following information:




SEC Form 4 filing: Jan 20: Sold 820 shares at the rate of $33.24 per share. Total worth of this trade was $27,253. Total number of shares owned as of Jan 20 were 9,680




					Posted by  



George Daniels 

					
					on Monday July 24 2017, 10:22 PM EDT. 

All trademarks acknowledged. 
Filed under Stocks.

	Comments closed, Trackbacks open.	
 Follow responses: 
RSS 2.0




Comments are closed


 Latest News 
10% Owner of Barclays (NYSE:BCS), Barclays Plc, sells 750 shares worth $75,000,000
Chief Marketing Officer of GoDaddy Inc (NYSE:GDDY), Rechterman Barbara J, sells 17,500 shares worth $757,496
EVP, Chief Financial Officer of Red Hat (NYSE:RHT), Shander Eric Ryan, sells 1,521 shares worth $152,070
Director of Global Blood Therapeutics (NASDAQ:GBT), Patrick Deval L, sells 27,053 shares worth $803,204
CEO of Hewlett Packard Enterprise Comp (NYSE:HPE), Whitman Margaret C, sells 194,834 shares worth $3,484,606
Vice Chairman of American Expressny (NYSE:AXP), Squeri Stephen J, sells 94,792 shares worth $8,096,185
Former 10% owner(1) of Diana Containerships Inc (NASDAQ:DCIX), Peter Gyllenhammar Ab, sells 350,000 shares worth $80,500
See Remarks of MyoKardia (NASDAQ:MYOK), Bauer Jake, sells 4,333 shares worth $65,060
President and CEO of MyoKardia (NASDAQ:MYOK), Gianakakos Anastasios, sells 32,988 shares worth $494,902
Director of Aehr Test Systems (NASDAQ:AEHR), Posedel Rhea J, sells 1,500 shares worth $6,210

 


News Categories 
Business (7)

Stocks (15,623)



Entertainment (1,297)

Featured News (3,486)

Featured Press Release (253,412)

Finance (309)

Health (653)

Lifestyle (19)

Nation (90)

Non FirstPage (2)

Original (47)

Press Release (17)

Review (1)

Shopping (267)

Sports (613)

Technology (194)

Travel (286)

World (1,367)


  Featured Press Releases 
10% Owner of Barclays (NYSE:BCS), Barclays Plc, sells 750 shares worth $75,000,000
Chief Marketing Officer of GoDaddy Inc (NYSE:GDDY), Rechterman Barbara J, sells 17,500 shares worth $757,496
EVP, Chief Financial Officer of Red Hat (NYSE:RHT), Shander Eric Ryan, sells 1,521 shares worth $152,070
Director of Global Blood Therapeutics (NASDAQ:GBT), Patrick Deval L, sells 27,053 shares worth $803,204
CEO of Hewlett Packard Enterprise Comp (NYSE:HPE), Whitman Margaret C, sells 194,834 shares worth $3,484,606
Vice Chairman of American Expressny (NYSE:AXP), Squeri Stephen J, sells 94,792 shares worth $8,096,185
Former 10% owner(1) of Diana Containerships Inc (NASDAQ:DCIX), Peter Gyllenhammar Ab, sells 350,000 shares worth $80,500
See Remarks of MyoKardia (NASDAQ:MYOK), Bauer Jake, sells 4,333 shares worth $65,060
President and CEO of MyoKardia (NASDAQ:MYOK), Gianakakos Anastasios, sells 32,988 shares worth $494,902
Director of Aehr Test Systems (NASDAQ:AEHR), Posedel Rhea J, sells 1,500 shares worth $6,210







Business
Finance
Sports
Entertainment
Health
Technology
Travel
Shopping
 

About Us
Contact Us
Privacy Policy
Advertise
Press Releases
Terms Of Service
 
Log in 















PBYI Charles R. Eyler Insider Trades for Puma Biotechnology Inc.


































Bulletin






Investor Alert







London Markets Close in:



Currencies
Futures
Metals Stocks


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Puma Biotechnology Inc.

                  NASDAQ: PBYI
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Puma Biotechnology Inc.



Market open
 --Real time quotes
Jul 28, 2017, 11:29 a.m.


PBYI

/quotes/zigman/83274811/composite


$
97.55




Change

+0.90
+0.93%

Volume
Volume 198,343
Real time quotes








/quotes/zigman/83274811/composite
Previous close

$
			96.65
		


$
				97.55
			
Change

+0.90
+0.93%





Day low
Day high
$94.80
$98.10










52 week low
52 week high

            $28.35
        

            $98.85
        


















Insider Activity


Individual




Charles R. Eyler



Mr. Charles R. Eyler is Treasurer & Senior VP-Finance & Administration at Puma Biotechnology, Inc.
Mr. Eyler was previously employed as Treasurer & Senior Vice President-Finance by Cougar Biotechnology, Inc., Treasurer & Vice President-Finance by Cougar Biotechnology, Inc., Chief Operating & Financial Officer by Hayes Medical, Inc., a Director-Finance & Administration by Alphatec Spine, Inc., a Director-Financial Systems by Zimmer, Inc., Division Controller by JBL Scientific, Inc., Division Controller by Surgitek, Inc., and Treasurer & Senior Vice President-Finance by Innovative Acquisitions Corp.
He received his undergraduate degree from Drexel University and an MBA from St. Francis College.



Transactions


Date
Shares
Transaction
Value





07/20/2017
662


 
Disposition at $95.15 per share.


62,990


05/31/2017
21,000


 
Award at $0 per share.


0


01/20/2017
820


 
Disposition at $33.24 per share.


27,257


10/14/2016
10,500


 
Award at $0 per share.


0





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. Alan H. Auerbach 
Chairman, President, CEO & Secretary




Mr. Charles R. Eyler 
Treasurer & Senior VP-Finance & Administration




Mr. Steven  Lo 
Chief Commercial Officer




Dr. Robert  Charnas 
Senior VP-Regulatory Affairs & Project Management




Dr. Richard Benton Phillips 
Head-Regulatory Affairs & Quality Assurance




Mr. Frank E. Zavrl 
Independent Director




Dr. Adrian M. Senderowicz 
Independent Director




Mr. Jay M. Moyes 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




11:29 AM EDT
July 28, 2017


/marketstate/country/us
New York

	Open


/marketstate/country/uk
London

	Open


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
11:27aWhat is an ICO?
11:22aOne way you’re paying credit-card fees, even if you don’t have a card
11:18aStock market edges lower, on track for weekly losses 
11:18aOil sets sights on biggest weekly gain of the year
11:16aUPDATE: Invisalign maker Align stocks surge 8% after earnings blow past estimates
11:12aAirbus to sell plant holdings to Motorola
11:11aAmerican Airlines profit falls, unit revenue gains
11:11aChevron swings to profit as charges shrink
11:11aSears Canada's biggest shareholders call off bid
11:10aRedfin's stock debuts 30% above its IPO price
11:10aTime for GOP to face reality: Everybody is going to have health insurance
11:09aBP earnings: What to expect
11:09aExxon, Chevron post strong profits 
11:08aChina penalizes nine banks for forex violations
11:06aRedfin's stock opens at $19.56, or 30% above $15 IPO price
11:03aEurope’s refugee crisis won’t be solved in a distant court
11:01aWhat Trump could do to make Obamacare ‘implode’
10:58aFoxconn’s history of broken promises casts a shadow on Wisconsin news
10:56aHere’s something that can improve your memory — and help you sleep
10:56a$1 million or $5,000 a month: which would you choose?
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,777.83

-18.72
-0.09%





nasdaq

/quotes/zigman/12633936/realtime
6,360.58

-21.61
-0.34%





s&p 500

/quotes/zigman/3870025/realtime
2,467.49

-7.93
-0.32%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15
























































Charles Eyler, Puma Biotechnology Inc: Profile & Biography - Bloomberg


































































  























Feedback





Charles Eyler

Senior VP:Finance & Administration/Treasirer,
Puma Biotechnology Inc






Career History




Senior VP:Finance & Administration/Treasirer
Puma Biotechnology Inc, 10/2011-PRESENT



Puma Biotechnology Inc, 9/2011-10/2011


Senior VP:Finance/Treasurer
Cougar Biotechnology Inc, 9/2008-7/2009


VP:Finance/Treasurer
Cougar Biotechnology Inc, 4/2006-9/2008


VP:Finance
Cougar Biotechnology Inc, 9/2004-4/2006


Show More









Website:
www.pumabiotechnology.com






Corporate Information
Address:

10880 Wilshire Blvd
Suite 2150
Los Angeles, CA 90024
United States


Phone:
1-425-248-6500


Fax:
1-424-248-6501


Web url:
www.pumabiotechnology.com











From The Web












Personal Information



Education



Drexel University
Bachelor's Degree


St Francis College
MBA








Sponsored Financial Commentaries







More From The Web


















Home


News


Top Headlines
Most Popular
Exclusive
Law
Entrepreneurs
Leaders
Economy
Environment
Science
Sports
Markets Magazine
Pursuits Magazine
Bloomberg Visual Data
Bloomberg Best (and Worst)
For comments or complaints about news coverage click here


Regions
U.S.
China
Europe
Asia
U.K. & Ireland
Australia & New Zealand
Canada
India & Pakistan
Japan
Africa
Eastern Europe
Latin America
Middle East
Markets
Commodities
Currencies
Bonds
Stocks
Energy Markets
Municipal Bonds
Emerging Markets
Funds
Islamic Finance
Industries
Energy
Technology
Real Estate
Finance
Health Care
Transportation
Insurance
Retail
Media
Manufacturing




Quick


Market Data


Stocks
Stock Futures
World Indexes
Americas
Europe, Middle East, & Africa
Asia-Pacific
Gainers & Losers
Earnings Calendar
Industry Leaders
Currencies
Americas
Europe, Middle East, & Africa
Asia-Pacific
Foreign Exchange Cross Rates
FX Fixings
Currency Converter
Forex Trading Videos
Commodities
Energy Prices
Metals Prices
Agricultural Prices


Rates & Bonds
US Treasuries
UK Gilts
Germany Bunds
Japan Bonds
Australia Bonds
Bloomberg Bond Indexes
Corporate Bonds
Consumer Rates
Economic Calendar
Watchlist
European Debt Crisis
Symbol Search
The Market Now




Personal Finance


Top Headlines
Saving & Investing
Real Estate
Retirement Planning
Financial Advisers
Taxes
Blog: Ventured & Gained
Real Cost Of
Money Gallery
Calculators
Watchlist (Portfolio Tracker)




Tech


Top Headlines
Social Media
Mobile & Wireless
Web
Enterprise Tech
TV, Games & Movies
Apple
Tech Deals
Global Tech
Slideshows
Videos




U.S. Politics


Sustainability


Top Headlines
Energy
Corporate Sustainability
Policy
Natural Resources
Health & Population
Slideshows
Videos
Blog: The Grid




Luxury


Top Headlines
Autos
Billionaires
Living
Property
Travel
Well Spent
Loot Blog
Pursuits Magazine
Videos




TV


Live TV
Channel Finder
Personalities
Apple TV
iPad App
Schedule
U.S.
Asia
Europe


Shows
Surveillance
Market Makers
Lunch Money
Street Smart
Bloomberg West
Game Changers




Video


Must See
Latest
Live TV
Shows
Playlist




Radio


Live Radio
Shows
Schedule
Personalities
Podcasts
Bloomberg Brief
Featured Podcasts and New Shows
Bloomberg View
Masters in Business
First Word
Surveillance
Bloomberg Advantage
In the Loop
Bloomberg Law
Taking Stock
Bloomberg Best
More Podcasts




Blogs


Global Tech
The Grid
Loot
The Market Now
Political Capital
Tech Deals
Ventured and Gained




Opinion




My Saved



Registration



Sign In



Bloomberg.com



Businessweek.com



Company



About
Blog
Careers
Diversity & Inclusion
News Mission
Philanthropy & Engagement
Press Room
Procurement
Sustainability




Products



Financial Products
Bloomberg Professional Service
Bloomberg Anywhere
Bloomberg Tradebook
Bloomberg Briefs
Bloomberg Indexes
Bloomberg SEF
Service Center
Customer Support
Enterprise Products
Enterprise Solutions
Trading Solutions
Industry Products
Bloomberg BNA
Bloomberg Government
Bloomberg Law
Bloomberg Link
Bloomberg New Energy Finance
Bloomberg Sports
Content Licensing




Bloomberg Anywhere



Mobile Apps



Bloomberg Visual Data


































Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft


















Charles R. Eyler - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Charles R. Eyler
Former Senior Vice President, Finance and Administration and Treasurer at Puma Biotechnology, Inc.


View Full Profile
Are you Charles R. Eyler? Claim your profile


 


Sign up for Equilar Atlas and view Charles R. Eyler's full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Charles R. Eyler's  network and community.
												FOLLOW changes in Charles R. Eyler's employment and money-in-motion.
												CONNECT with Charles R. Eyler through your network of contacts.
												








Charles R. Eyler's Executive Work History


Past
To view Charles R. Eyler's complete executive work history, sign up now
Age
69

 
 


Charles R. Eyler's Biography



Mr. Eyler has served as our Senior Vice President, Finance and Administration and Treasurer since October 2011. Prior to October 2011, he served in such capacity at Puma beginning in September 2011. Prior to joining Puma, Mr. Eyler served as Senior Vice President of Finance at Cougar until July 2009, when Cougar was acquired by Johnson & Johnson. He also served as Treasurer of Cougar from April 2006 to July 2009. From July 2009 until March 2010, Mr. Eyler served on the Integration Steering Committee at Cougar (as part of Johnson & Johnson) and oversaw the integration of Cougar's finance and IT functions with those of Johnson & Johnson. From A ...
(Read More)

			Mr. Eyler has served as our Senior Vice President, Finance and Administration and Treasurer since October 2011. Prior to October 2011, he served in such capacity at Puma beginning in September 2011. Prior to joining Puma, Mr. Eyler served as Senior Vice President of Finance at Cougar until July 2009, when Cougar was acquired by Johnson & Johnson. He also served as Treasurer of Cougar from April 2006 to July 2009. From July 2009 until March 2010, Mr. Eyler served on the Integration Steering Committee at Cougar (as part of Johnson & Johnson) and oversaw the integration of Cougar's finance and IT functions with those of Johnson & Johnson. From April 2010 until September 2011, Mr. Eyler explored various entrepreneurial and other opportunities. Prior to joining Cougar, Mr. Eyler served as Chief Financial Officer and Chief Operating Officer of Hayes Medical Inc. from March 1999 to January 2004. Mr. Eyler received his B.S. from Drexel University and his M.B.A. from Saint Francis College.
		
Source: Puma Biotechnology, Inc. on 04/28/2017
		
	

 






Sign up for Equilar Atlas and view Charles R. Eyler's full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Charles R. Eyler. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Charles R. Eyler's  network and community.
												FOLLOW changes in Charles R. Eyler's employment and money-in-motion.
												CONNECT with Charles R. Eyler through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Charles R. Eyler


















Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Carl G. Annessa
EVP and COO, Hornbeck Offshore Services, Inc.









Elon R. Musk
CEO and Chairman, Tesla









Michael C. Montgomery
Board Member, NMI Holdings, Inc.












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

ï¿½ 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993


















Charles R. Eyler - Treasurer & Senior Vice President-Finance & Administration at Puma Biotechnology, Inc.



























































                      NEWS HOME
                    

Advertising
Board and Executive Moves
Energy
Health Care
Hedge Funds
M & A
Private Equity
Technology








            You have  
            
9 free profiles

              left this month   
			      

                Start Your Free Trial ➤
              








            Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there?
            

                View on RelSci Pro ➤
              




























































































































Email







LinkedIn







Facebook







Google+







Tweet







Reddit





Permalink





Charles R. Eyler
Treasurer & Senior Vice President-Finance & Administration at Puma Biotechnology, Inc.



Overview
In The News Relationships Paths
Education Career History Boards & Committees Public Holdings Transactions 


Charles R. Eyler
Treasurer & Senior Vice President-Finance & Administration at Puma Biotechnology, Inc.



 Overview



Age



69
                                  (Born 1948)
                                              




Notable Companies


Consensus Orthopedics, Inc.




Board Seats



1





Number of Relationships



                This person is connected to 206 people.
              






 In The News
          See more




PR Newswire
November 11, 2016





                        Puma Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Puma Biotechnology, Inc. - PBYI                    





Business Wire
October 28, 2016





                        PUMA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Puma Biotechnology, Inc. - PBYI                    





Business Wire
October 14, 2016





                        PUMA INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Puma Biotechnology, Inc. - PBYI                    







 Relationships
              See Details




Alan H. Auerbach

Founder at Puma Biotechnology, Inc.




Richard B. Phillips

Vice President-Regulatory Affairs at Chugai Biopharmaceuticals, Inc.





Mariann Ohanesian

Senior Director, Investor Relations at Puma Biotechnology, Inc.




Russell H. Ellison

Senior Advisor & Head, Microbiome Program at Assembly Biosciences, Inc.





Harold J. Meyers

Former Senior Vice President at A.G. Edwards & Sons, Inc.




William F. Daly

President & Chief Executive Officer at Heart Metabolics Ltd.





Lindsay A. Rosenwald

Chairman, President & Chief Executive Officer at Fortress Biotech, Inc.




Arturo Molina

Chief Medical Officer at Sutro Biopharma, Inc.





Thomas W. Griffin

Vice President-Clinical Research & Development at Cougar Biotechnology, Inc.




Cheryl Collett

Controller at Puma Biotechnology, Inc.







See 196 more listings with RelSci Professional.

Start My Free Trial ➤








See 196 More 


 


 Paths to Charles R. Eyler



            Charles R. Eyler          




 You



 Connections via Relationship Science



 Charles R. Eyler






Sync your contacts to see how you can connect with Charles R. Eyler.

Start My Free Trial ➤








See  More 


 


 Educational Background



BS Degree 


Drexel University

                  Drexel is a comprehensive global research university ranked among the top 100 in the nation. With approximately 25,000 students, Drexel is one of America’s 15 largest private universities.

Drexel has built its global reputation on core achievements that include:

    Leadership in experiential learning through Drexel Co-op.
    A history of academic technology firsts.
    Recognition as a model of best practices in translational, use-inspired research.

Founded in 1891 in Philadelphia, Drexel now engages with students and communities around the world via:

    Three Philadelphia campuses and other regional sites.
    Drexel University Sacramento
    The Academy of Natural Sciences of Drexel University, the nation’s oldest major natural science museum and research organization.
    International research partnerships including China and Israel.
    Drexel Online, one of the oldest and most successful providers of online degree programs.

Drexel is one of Philadelphia’s top 10 employers, and a major engine for economic development in the region. Drexel has committed to being the nation’s most civically engaged university, with community partnerships integrated into every aspect of service and academics.

Drexel’s ongoing strategic plan, “Transforming the Modern Urban University,” guides the University’s 21st-century trajectory.                




MBA 


St. Francis College

                  ST. FRANCIS COLLEGE IS AN INDEPENDENT, COEDUCATIONAL INSTITUTION OF HIGHER EDUCATION CHARTERED BY AN ACT OF THE REGENTS OF THE UNIVERSITY OF THE STATE OF NY ON APRIL 10,1957.                





 Career History



Treasurer & Senior Vice President-Finance & Administration

                                    2011 - Current                


Puma Biotechnology, Inc.


                  Puma Biotechnology, Inc. is a development stage biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. The company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. Puma Biotechnology was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.                




Treasurer & Senior Vice President-Finance

                                    Prior - 2011                


Innovative Acquisitions Corp.


                  Innovative Acquisitions Corp. operates as a blank check company. It engages in organizational efforts and obtaining initial financing. The firm intends to acquire or merge with an existing company. The company was founded on April 27, 2007 and is headquartered in Cumberland, RI.                




Treasurer & Senior Vice President-Finance

                                    2004 - 2009                


Cougar Biotechnology, Inc.


                  Cougar Biotechnology, Inc. develops pharmaceutical products for the treatment of cancer. The company was founded in 2003 and is headquartered in Raritan, NJ.                




Vice President of Finance

                                    2004 - 2009                


Cougar Biotechnology, Inc. (Inactive)


                  Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA.                




Chief Operating & Financial Officer

                                    1999 - 2004                


Consensus Orthopedics, Inc.


                  Consensus Orthopedics, Inc. provides total joint implants and instruments. Its products include Consensus knee and hip and CS2 Acetabular Cup systems. The company was founded in July 1992 and is headquartered in El Dorado Hills, CA.                




Division Controller

                                    Prior                


JBL Scientific, Inc.


                  JBL Scientific, Inc., part of Promega Corp., is a company headquartered in the United States that makes specialty chemical products. The firm was acquired by Promega Corp. from Genta, Inc. on 11 May 99.                




Division Controller

                                    Prior                


Surgitek, Inc.






Director-Finance & Administration

                                    Prior                


Alphatec Spine, Inc.


                  Alphatec Spine, Inc. is focused on the design, development, manufacturing, and marketing of products for the surgical treatment of spine disorders, with a focus on treating condition affecting the aging spine. The firms product portfolio and pipeline include spinal disorder products and systems. The company was founded in 1990 and is headquartered in Carlsbad, CA.                




Director-Financial Systems

                                    Prior                


Zimmer, Inc.


                  Zimmer, Inc. provides joint replacement solutions. The firm products include trauma and dental implants and orthopaedic surgical products. The company was founded in 1927 and is headquartered in Warsaw, IN.                





 Boards & Committees



Corporate Boards ▾




Treasurer

                    Prior - 2009                  


Cougar Biotechnology, Inc. (Inactive)

                    Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA.                  





 Public Holdings






Restricted data only for RelSci Professional users.

Start My Free Trial ➤








See  More 


 


 Transactions



 Details Hidden



                  Puma Biotechnology, Inc. raised money in a private placement transaction                                  




 Details Hidden



                  Puma Biotechnology, Inc. raised money in a private placement transaction                                  





 Other Affiliations




              Charles R. Eyler is affiliated with
                            Puma Biotechnology, Inc., Innovative Acquisitions Corp., Cougar Biotechnology, Inc., Cougar Biotechnology, Inc. (Inactive), Consensus Orthopedics, Inc., JBL Scientific, Inc., Surgitek, Inc., Alphatec Spine, Inc., Zimmer, Inc., Cougar Biotechnology, Inc. (Inactive).
            





You've reached your 10 free profiles limit this month.
Upgrade to RelSci Pro today to enjoy unlimited article views and much more!

Start My Free Trial  ➤

Still not convinced? Check out our full listing of features here.












Are you a RelSci Pro Subscriber?

Login to RelSci Pro 
                        ➤


Not a Pro Subscriber? Log in here to manage your alerts









 Keep me signed in.
        

Login  ➤



        Forgot your Password?
    

























 I have read the LexisNexis terms & conditions




Sign Me Up  ➤













